View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
August 3, 2017

Deals this week: Aethlon Medical, Accuray, Amoy Diagnostics

Aethlon Medical Inc plans to issue shares of its common stock in a public offering to raise up to $13.28m.

Aethlon Medical Inc plans to issue shares of its common stock in a public offering to raise up to $13.28m.

The American company plans to use the funds to progress the development of its products as well as towards working capital and general corporate purposes.

US-based radiation oncology company Accuray Inc has announced the private placement of senior unsecured notes to raise $32m.

Due 15 July 2022, the notes carry an interest rate of 3.75% a year.

Accuray plans to use the funds to repurchase $28m of existing notes.

"Amoy plans to use the funds from the IPO towards new product investment, marketing, and R&D expansion."

Chinese molecular diagnostics company Amoy Diagnostics Co Ltd has announced the completion of an initial public offering (IPO) of 20 million shares priced at CNY13.86 ($2.06) each to raise CNY277m ($41.21m).

Amoy plans to use the funds from the IPO towards new product investment, marketing, and R&D expansion.

Invitae Corp plans to issue eight million preferred shares, priced at $8.5 a share, in a private placement to raise $73.5m.

The US-based genetic information company plans to use the proceeds to expand its business.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU